Company Profile - March 2012
In the high desert plains of the American Southwest, a Canadian startup company has created a perfect storm of omega-3 opportunity.
Algae Biosciences Corporation (TSX.V:ABV) expects to reach full commercial production of its ultra-pure, vegetable-based omega-3 fatty acid oils during the second quarter of 2012.
Plentiful Arizona sunshine, scientific resourcefulness, technological advances, and a pristine source of saline groundwater have all combined to produce highly regarded algal oils — which include equal proportions of the essential fatty acids EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) at a blended ratio of 40 per cent.
Between our consistent sunlight exposure, our ultra-pure water supply, and our advanced proprietary technology, AlgaeBio has the best algae-growing conditions in the world,” says AlgaeBio chairman Robert J. Thompson. “We can produce the highest quality omega-3 fatty acid oils available on the market.” AlgaeBio (www.algaebio.com) and its operating subsidiary, Algae Biosciences Incorporated, are in the final stages of a $5-million, first-phase expansion of their production facilities near Holbrook, Ariz.
The company’s proprietary bioreactors were developed with the assistance of one of the world’s most celebrated centres for algae research, Arizona State University’s Arizona Center for Algae Technology and Innovation (AzCATI).
AlgaeBio co-founder Andrew Ayers has refined an array of specific algae strains that are ideal for the Holbrook facility’s near-perfect growing environment. Because AlgaeBio uses photosynthesis to grow its algae, rather than batch fermentation, its resulting omega- 3 fatty acid oils also include compounds such as carotenoids, phytosterols, chlorophyll, and antioxidants that provide even more health benefits. Unlike some of its competitors, AlgaeBio also uses a supercritical carbon dioxide (CO2) extraction process rather than using hexane, a hydrocarbon-based solvent.
Thanks to a U.S. patent, AlgaeBio enjoys the exclusive right to culture marine species from the Coconino Aquifer, an ancient underground sea that produces remarkably pure saline groundwater — the perfect medium for growing marine algae.
AlgaeBio has a long-term agreement in place with Global Health Trax, Inc. of Vista, Calif., that gives GHT exclusive rights to purchase and distribute AlgaeBio’s ultra-pure omega-3 products destined for the nutraceutical, food additive, and animal feed markets.
Algae Biosciences Corporation (TSX.V:ABV) expects to reach full commercial production of its ultra-pure, vegetable-based omega-3 fatty acid oils during the second quarter of 2012.
Plentiful Arizona sunshine, scientific resourcefulness, technological advances, and a pristine source of saline groundwater have all combined to produce highly regarded algal oils — which include equal proportions of the essential fatty acids EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) at a blended ratio of 40 per cent.
Between our consistent sunlight exposure, our ultra-pure water supply, and our advanced proprietary technology, AlgaeBio has the best algae-growing conditions in the world,” says AlgaeBio chairman Robert J. Thompson. “We can produce the highest quality omega-3 fatty acid oils available on the market.” AlgaeBio (www.algaebio.com) and its operating subsidiary, Algae Biosciences Incorporated, are in the final stages of a $5-million, first-phase expansion of their production facilities near Holbrook, Ariz.
The company’s proprietary bioreactors were developed with the assistance of one of the world’s most celebrated centres for algae research, Arizona State University’s Arizona Center for Algae Technology and Innovation (AzCATI).
AlgaeBio co-founder Andrew Ayers has refined an array of specific algae strains that are ideal for the Holbrook facility’s near-perfect growing environment. Because AlgaeBio uses photosynthesis to grow its algae, rather than batch fermentation, its resulting omega- 3 fatty acid oils also include compounds such as carotenoids, phytosterols, chlorophyll, and antioxidants that provide even more health benefits. Unlike some of its competitors, AlgaeBio also uses a supercritical carbon dioxide (CO2) extraction process rather than using hexane, a hydrocarbon-based solvent.
Thanks to a U.S. patent, AlgaeBio enjoys the exclusive right to culture marine species from the Coconino Aquifer, an ancient underground sea that produces remarkably pure saline groundwater — the perfect medium for growing marine algae.
AlgaeBio has a long-term agreement in place with Global Health Trax, Inc. of Vista, Calif., that gives GHT exclusive rights to purchase and distribute AlgaeBio’s ultra-pure omega-3 products destined for the nutraceutical, food additive, and animal feed markets.
